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Objectives. Retrospective study was designed to examine the importance of tissue kidney injury molecule-1 (KIM-1) expression
in predicting kidney function in sixty patients (27 males) aged 34.15 ± 12.23 years with different kidney diseases over three years
after kidney biopsy.Materials and Methods. Tissue KIM-1 expression was determined immunohistochemically and KIM-1 staining
was scored semiquantitatively, as well as tubulointerstitialis (TIN), inflammation, atrophy, and fibrosis. Kidney function (MDRD
formula) and proteinuria/day were evaluated at the time of biopsy (GFR0) and 6, 12, 24, and 36 months later. Results. Significantly
positive correlations between tissue KIM-1 expression and age (𝑟 = 0.313), TIN inflammation (𝑟 = 0.456), fibrosis (𝑟 = 0.317),
and proteinuria at 6 months (𝑟 = 0.394) as well as negative correlations with GFR0 (𝑟 = −0.572), GFR6 (𝑟 = −0.442), GFR24
(𝑟 = −0.398), and GFR36 (𝑟 = −0.412) were found. Meanwhile, TIN inflammation was the best predictor of all measured kidney
functions during three years, while tissue KIM-1 expression (𝑃 = 0.016) was a predictor only at 6 months after biopsy. Conclusion.
Tissue KIM-1 expression significantly predicts kidney function solely at 6 months after biopsy, when the effects of immune and
nonimmune treatments are the strongest.
1. Introduction
Chronic kidney disease (CKD) is associated with a number of
comorbidities and prognosis is poor, because many patients
experience progression to end-stage renal disease [1]. Also, in
the majority of patients disease progression may be altered
due to more or less suitable immunosuppressive protocol
treatments and therapeutic approaches. The mechanisms of
injury underlying progression are blurred, but traditional
opinion pointed to an association between decline in renal
function with the degree of proteinuria and histological
findings of glomerulosclerosis and interstitial fibrosis [2, 3].
Kidney injury molecule-1 (KIM-1) is a new specific
biomarker of proximal tubule injury that can be measured
both in urine and kidney tissue samples. It is an apoptotic-cell
phagocytosis and scavenger receptor that is most highly
upregulated in proximal tubular epithelium in acute and
chronic kidney injury [4]. Also, much attention has been
paid to its possible pathophysiological role in modulation of
tubular damage and repair [5–7].
Besides a close relationship between tissue KIM-1 expres-
sion and urinary KIM-1 concentration, our previous six-
month prospective pilot study showed that KIM-1 expression
in tissue correlated better with TIN features and renal func-
tion in different chronic kidney diseases than with urinary
KIM-1 concentration [8]. Therefore, that investigation was
the basis of this long-term retrospective study, where only
KIM-1 tissue expression as a predictor of long-term kidney
function was examined.
The aim of this retrospective investigation was to eval-
uate (1) possible associations between tissue KIM-1 expres-
sion and tubulointerstitial (TIN) inflammation, atrophy,
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and fibrosis in different chronic kidney diseases and (2)
possible associations between tissue KIM-1 expression and
some demographic and laboratory parameters as well as
kidney function and proteinuria at the time of biopsy and 6,
12, 24, and 36 months later.
2. Methods
2.1. Patients. The retrospective study included 60 patients (27
men) ofmean age 34.42± 12.15 years (range 18–59 years), who
were hospitalized in the Clinical Center of Serbia for kidney
biopsy from 2006 to 2009. Indications for kidney biopsy
were nephrotic syndrome, pathologic proteinuria without
nephrotic syndrome, and abnormal urinary sediment (ery-
throcyturia and leukocyturia) in several samples.
Pathohistological analysis revealed minimal change
glomerulonephritis (MCGN) in two patients, non-IgA GN
in nine, IgA GN in six, membranous and membranoprolif-
erative GN in seven patients each, focal glomerulosclerosis in
eleven, lupus nephritis in ten, and crescentic GN in eight
patients. After diagnosis, the participants were treated
according to established protocols for each type of GN with
immunological and nonimmunological therapy (nonsalt
diets, statins, angiotensin-converting-enzyme-ACE inhibi-
tors, and angiotensin receptor type 1 blockers ATB).
The investigation was planned according to the ethical
guidelines of the Declaration of Helsinki. The institutional
review committee approved our study protocol therebys
following local biomedical research regulations (IRB No.
877/7).
2.2. Laboratory Methods. A complete blood count; serum
urea and creatinine, albumin; lipid status, and urine sediment
were determined in blood and urine samples collected 1 day
before kidney biopsy as well proteinuria/day. Only samples
with a sterile urine culture were processed. Urine sediments
with more than 3 RBC/hpf or 5 WBC/hpf were defined
as clinically significant erythrocyturia or leukocyturia. Esti-
mated glomerular filtration rate (eGFR) was calculated with
a shortened version of the Modification of Diet in Renal
Disease (MDRD; patients ≥18 years) [9].
2.2.1. Morphological Changes. Alteration in TIN were
assessed after routine hematoxylin-eosin staining by a quali-
fied nephropathologist who was not familiar with the preset
histopathologic or clinical diagnosis, nor the identity of
patients. Inflammation activity was then scored numerically
(0: no inflammation, 1: slightly marked inflammation, 2:
moderate inflammation, and 3: strong inflammation) as well
as atrophy and fibrosis advancement (0: no atrophy and no
fibrosis, 1: slightly marked atrophy and fibrosis, 2: moderate
atrophy and fibrosis, 3: very pronounced atrophy and
fibrosis).
2.2.2. Kim-1 Expression in Tissue. After deparaffinization
tissue samples were rehydrated and stained immunohisto-
chemically for KIM-1 using the tissue KIM-1/TIM-1 kit (R
& D Systems Inc., Minneapolis, MN, USA) with contrasting
Table 1: Tissue samples scoring systembased on percentage ofKIM-
1 positive tubules.







hematoxylin and eosin staining. A tubule was considered to
be KIM-1 positive if it contained at least one KIM-1 positive
cell regardless of whether the KIM-1 expression was cytoplas-
mic or apical. KIM-1 staining was scored semiquantitatively
by estimating the percentage of cortical tubules expressing
KIM-1 per field (the complete biopsy area was scored, with
a minimum of five fields; in controls 30 fields were scored).
Then the score was assigned to each tissue sample as shown
in Table 1 [10]. Unaffected parts of kidneys from patients with
renal cell carcinoma were used as the negative control.
The 6-, 12-, 24-, and 36-month followup for all patients
included measurement of serum creatinine concentration,
eGFR, and proteinuria.
2.3. Statistics. Data are presented as mean ±1 standard
deviation (SD) and the range of values. The one-sample
Kolmogorov-Smirnov test was used to check for normal
distribution of the variables. Relationships between vari-
ables were estimated using Pearson’s rank and Spearmen’s
correlation tests as appropriate. Correlations or differences
were considered statistically significant if two-tailed 𝑃 <
0.05. Independent predictors of renal function 6, 12, 24,
and 36 months after the kidney biopsy were identified by
stepwise multivariant regression analysis. All calculations
were performed using SPSS software.
3. Results
Table 2 presents the demographic, clinical, and laboratory
data for the patients at the time of kidney biopsy.
Tissue KIM-1 expression was significantly induced in
all kidney biopsies except in one patient with MCGN.
Tissue KIM-1 had a typically apical localization, but it could
also be found in the cytoplasm with no apparent affinity for
the apical membrane of tubulocytes. KIM-1 positive tubules
were located mainly in the TIN regions affected by inflam-
mation or fibrosis but were not observed in regions with
end-stage fibrosis. KIM-1 positive tubules were often dilated
cortical tubules, sometimes with initial signs of atrophy.
Completely atrophic tubules were KIM-1 negative (Figure 1).
Univariate analysis showed significant positive associa-
tions between tissue KIM-1 expression and age (𝑟 = 0.313;
𝑃 = 0.015), TIN inflammation (𝑟 = 0.4563; 𝑃 = 0.004), TIN
fibrosis (𝑟 = 0.317; 𝑃 = 0.021), and hemoglobin (𝑟 = −0.440;
𝑃 = 0.001) as well as negative associations with albumin con-
centration (𝑟 = −0.376; 𝑃 = 0.011) and eGFR (𝑟 = −0.572;
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Figure 1: KIM-1 positive tubules are of intense red color. (a) Apical membrane of tubulocytes has the strongest affinity for KIM-1 specific
antibodies. (b) Entire cytoplasm of tubulocytes has strong affinity for KIM-1 specific antibodies.
Table 2: Demographic, clinical, and laboratory data of patients at
the time of kidney biopsy.
Variables 𝑋 ± SD
Age (years) 34.42 ± 12.15
Gender (M/F) 27/33
MAP (mmHg) 98.55 ± 10.17
Hemoglobin (g/L) 122.40 ± 27.28
Albumin (g/L) 29.08 ± 9.73
Serum creatinine (𝜇mol/L) 185.50 ± 186.28
eGFR (mL/min/1.73m2) 58.39 ± 35.93
Proteinuria (g/day) 5.25 ± 4.36
MAP: mean arterial pressure; eGFR: estimated glomerular filtration rate.
𝑃 < 0.001) at the time of biopsy and 6 (𝑟 = −0.442; 𝑃 =
0.002), 24 (𝑟 = −0.398; 𝑃 = 0.012), and 36 (𝑟 = −0.412;
𝑃 = 0.015) months later. Tissue KIM-1 expression correlated
significantly only with proteinuria/day 6 months after biopsy
(𝑟 = 0.394; 𝑃 = 0.026) but not with proteinuria at the time of
biopsy and 12, 24, and 36 months later.
Table 3 gives the correlation coefficients between eGFR at
the time of biopsy and 6, 12, 24, and 36 months later and the
examined variables.Multivariant stepwise regression analysis
showed that the best predictor of kidney function at the time
of biopsy (eGFR 0) was TIN inflammation (𝑃 < 0.001), as
well as of eGFR12 (𝑃 = 0.015), eGFR 24 (𝑃 = 0.039), and
eGFR 36 (𝑃 = 0.012). However tissue KIM-1 expression was
the best predictor of eGFR 6 (𝑃 = 0.016) along with TIN
inflammation (𝑃 = 0.016) (Table 4). Figure 2 presents the
linear correlation between TIN inflammation (𝑃 < 0.001),
tissue KIM-1 expression (𝑃 < 0.001), and eGFR 6.
4. Discussion
In our previous 6-month prospective study, we found higher
urine KIM-1 concentrations in twenty chronic renal patients
than in control subjects and a significant positive correlation
between urineKIM-1 level andKIM-1 expression in tissue [8].
Although, urineKIM-1 content reflected tissueKIM-1 expres-
sion, tissue KIM-1 correlated better with TIN inflammation
and fibrosis as well as with kidney function at the time of
biopsy and 3 and 6months later.Therefore, we retrospectively
examined sixty patients with different kidney diseases in
order to evaluate the importance of tissue KIM-1 expression
in predicting kidney function in the ensuing 36 months after
kidney biopsy.
In the present study tissue KIM-1 expression was associ-
ated with both TIN inflammation activity and TIN fibrosis.
In addition, KIM-1 positive tubules were located in parts
of the cortex that were imbued with inflammatory infiltrate
and/or fibrotic changes but not in completely atrophic areas.
It is well known that the expression of KIM-1 in tubules is
associated with inflammation and TIN damage [11]. Double-
labeling studies have shown simultaneous expression ofKIM-
1 and markers of prefibrotic changes, repair, and chemo-
taxis [10, 11]. The study of van Timmeren et al. [10] also
demonstrated a connection between KIM-1 expression in
tissue, interstitial fibrosis, and macrophage accumulation.
Ichimura et al. [7] first showed that tubular epithelial cells
expressing KIM-1 on their surface could act as phagocytes
for apoptotic and necrotic renal epithelial cells. KIM-1 is
expressed predominantly in renal tubules, which, judging
by the simultaneous expression of markers of dedifferenti-
ation [10], are currently under the influence of agents that
cause injury, but is absent from completely atrophic tubules.
Controversy remains about the function of KIM-1: is it
actively regulating the inflammatory process? or is its expres-
sion just a response to damage, attempted recovery, and/or
repair? [11].
The present study revealed a significant negative corre-
lation between tissue KIM-1 expression and all estimated
GFR at the time of kidney biopsy and 6, 24, and 36 months
later. However multivariate analysis pointed to TIN inflam-
mation, but neither TIN fibrosis nor proteinuria, as the best
predictor of kidney function at biopsy and 6, 12, 24, and 36
months afterwards. However, along with TIN inflammation,
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Table 3: Correlation coefficients between eGFR at the time of biopsy and 6, 12, 24, and 36 months later and measured variables.
eGFR 0 eGFR 6 eGFR 12 eGFR 24 eGFR 36
Age −0.273 — — — —
KIM-1 tissue expression −0.572 −0.340 — −0.378 −0.374
TIN atrophy −0.444 −0.305 −0.403 — —
TIN inflammation −0.713 −0.309 −0.434 −0.369 −0.518
TIN fibrosis −0.378 −0.381 −0.352 — —
Prt 0 — — — — —
Prt 6 — — −0.575 −0.511
TIN: tubulo-interstitialis; eGFR 0: estimated glomerular filtration rate at the time of biopsy; eGFR 6: estimated glomerular filtration rate 6 months after biopsy;
eGFR 12: estimated glomerular filtration rate 12 months after biopsy; eGFR 24: estimated glomerular filtration rate 12 months after biopsy; eGFR 24: estimated
glomerular filtration rate 24 months after biopsy; eGFR 36: estimated glomerular filtration rate 36 months after biopsy.
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Figure 2: Linear correlation between TIN inflammation (𝑃 = 0.000), tissue KIM-1 expression (𝑃 = 0.000), and eGFR 6 months after kidney
biopsy.
tissue KIM-1 expression was the best predictor of kidney
function 6 months after biopsy.
Interstitial infiltration of inflammatory cells can be seen
in a variety of immune and nonimmune kidney diseases
and is thought to play a significant role in TIN damage
and fibrosis. Upon exposure to high protein concentrations,
renal tubule cells produce a host of chemokines, vasoactive
mediators, and adhesion molecules, which may contribute to
interstitial fibrosis [12]. Protocol immunosuppressive therapy
and treatment with ACE inhibitors and AT blockers for
chronic renal patients with different chronic immune and
nonimmune-mediated kidney disorders proven by biopsy
have the strongest effects during the first 6 months of
therapy. The severity of pretreatment TIN damage predicts a
dulled response to renoprotective intervention, with a worse
long-term renal outcome [13]. Therefore, we can speculate
that patients with less interstitial inflammation at the time
of kidney biopsy will have a more favorable response to
treatment and better kidney function afterwards. Also, the
finding that KIM-1 was the strongest predictor of kidney
function 6months after biopsy along with TIN inflammation
may support the hypothesis about its potential role in the
development of interstitial fibrosis and an unsatisfactory
treatment response.
Association between higher urinary KIM-1 levels and
poorer kidney function was found in some human studies
in native [10, 14] and transplanted kidneys [15] but data
on human tissue KIM-1 expression are scarce. Zhang et al.
[16] found that KIM-1 expression in transplant biopsies is a
sensitive measure of cell injury. In addition, they showed that
more intense KIM-1 staining predicts a better graft outcome
over the ensuing 18 months and speculated that its level of
expression may be an indicator of graft function recovery.
It is well known that proteinuria is an ominous biomarker
of progressive kidney disease [2] and our study revealed that
only proteinuria 6 months after kidney biopsy correlated
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Table 4: Results of stepwise multivariate regression analysis with estimated glomerular filtration rate 6 months after biopsy as dependant
variable.
Coefficientsa
Model Unstandardized coefficients Standardized coefficients 𝑡 Sig.
B Std. error Beta
TIN inflammation −15.878 4.482 −.493 −3.542 .001
TIN inflammation −11.763 4.511 −.366 −2.607 .013
KIM1 tissue percent −.650 .259 −.353 −2.515 .016
aDependent variable: eGFR 6.
TIN: tubulointerstitialis; eGFR6: estimated glomerular filtration rate 6 months after biopsy.
negatively with kidney function 24 and 36 months after
the biopsies and positively with KIM-1 expression in tissue.
Earlier investigations [10, 14, 17] have yielded conflicting data
regarding the relationship between urinary KIM-1 level or
tissue KIM-1 expression and proteinuria. One explanation
may be that proteinuria is not always accompanied by TIN
damage and a progressive decline in renal function [18,
19]. Data regarding the selectivity of proteinuria were not
available for the purposes of this study.
5. Conclusion
Thepresent study exposed a strong association betweenKIM-
1 tissue staining and TIN inflammation and fibrosis but not
with TIN atrophy. Although multivariate analysis pointed to
TIN inflammation, as the best predictor of kidney function
at biopsy and 6, 12, 24, and 36 months later, tissue KIM-1
expression is one of the best predictor of kidney function
6 months after biopsy, the time when treatment effects are
the strongest. Therefore, we can speculate that KIM-1 has a
potential role in the development of interstitial fibrosis and
poor treatment responses.
The major limitation of this investigation is the relatively
small number of patients examined but it could be the basis
for a larger prospective follow-up study for evaluation of
urinary KIM-1 concentration and tissue KIM-1 expression in
patients with various chronic and acute renal diseases.
Conflict of Interests
All the authors have declared no competing interests.
Acknowledgment
This work was supported by a grant from the Ministry of
Science and Technological Development, Republic of Serbia
(Project no. 175089).
References
[1] F. Kronenberg, “Emerging risk factors and markers of chronic
kidney disease progression,” Nature Reviews Nephrology, vol. 5,
no. 12, pp. 677–689, 2009.
[2] K. Zandi-Nejad, A. A. Eddy, R. J. Glassock, and B. M. Brenner,
“Why is proteinuria an ominous biomarker of progressive
kidney disease?” Kidney International. Supplement, vol. 66, no.
92, pp. S76–S89, 2004.
[3] B. Rodr´ıguez-Iturbe, R. J. Johnson, and J. Herrera-Acosta,
“Tubulointerstitial damage and progression of renal failure,”
Kidney International. Supplement, vol. 68, no. 99, pp. S82–S86,
2005.
[4] T. Ichimura, C. R. Brooks, and J. V. Bonventre, “Kim-1/Tim-1
and immune cells: shifting sands,” Kidney International, vol. 81,
no. 9, pp. 809–811, 2012.
[5] G. J. Ko, D. N. Grigoryev, D. Linfert et al., “Transcriptional anal-
ysis of kidneys during repair fromAKI reveals possible roles for
NGAL and KIM-1 as biomarkers of AKI-to-CKD transition,”
TheAmerican Journal of Physiology—Renal Physiology, vol. 298,
no. 6, pp. F1472–F1483, 2010.
[6] T. Ichimura, J. V. Bonventre, V. Bailly et al., “Kidney injury
molecule-1 (KIM-1), a putative epithelial cell adhesionmolecule
containing a novel immunoglobulin domain, is up-regulated in
renal cells after injury,”The Journal of Biological Chemistry, vol.
273, no. 7, pp. 4135–4142, 1998.
[7] T. Ichimura, E. J. Asseldonk, B. D. Humphreys, L. Gunaratnam,
J. S. Duffield, and J. V. Bonventre, “Kidney injury molecule-1 is
a phosphatidylserine receptor that confers a phagocytic pheno-
type on epithelial cells,”The Journal of Clinical Investigation, vol.
118, no. 5, pp. 1657–1668, 2008.
[8] S. Simic Ogrizovic, S. Bojic, G. Basta Jovanovic, J. Kotur Stevul-
jevic, V.Dopsaj, andV. Lezaic, “Kidney injurymolecule-1 (KIM-
1) determination in tissue and urine of patients with different
kidney disease,” in Proceedings of the 50th ERA-EDTA Congress
Abstracts2View, 2011, http://www.abstracts2view.com/era.
[9] A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and
D. Roth, “A more accurate method to estimate glomerular
filtration rate from serumcreatinine: a newprediction equation.
Modification of diet in renal disease study group,” Annals of
Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999.
[10] M. M. van Timmeren, M. C. van den Heuvel, V. Bailly, S. J.
Bakker, H. van Goor, and C. A. Stegeman, “Tubular kidney
injury molecule-1 (KIM-1) in human renal disease,”The Journal
of Pathology, vol. 212, no. 2, pp. 209–217, 2007.
[11] F.Waanders,M.M. van Timmeren, C. A. Stegeman, S. J. Bakker,
and H. van Goor, “Kidney injury molecule-1 in renal disease,”
The Journal of Pathology, vol. 220, no. 1, pp. 7–16, 2010.
[12] T. W. Meyer, “Tubular injury in glomerular disease,” Kidney
International, vol. 63, no. 2, pp. 774–787, 2003.
[13] A. B. Kramer, H. Bos, H. van Goor, and G. J. Navis, “Sodium
intake modifies the negative prognostic value of renal damage
prior to treatment with ACE inhibitors on proteinuria induced
by adriamycin,” Nephron, vol. 103, no. 1, pp. p43–p52, 2006.
[14] H. P. E. Peters, F.Waanders, E.Meijer et al., “High urinary excre-
tion of kidney injury molecule-1 is an independent predictor
572 Disease Markers
of end-stage renal disease in patients with IgA nephropathy,”
Nephrology Dialysis Transplantation, vol. 26, no. 11, pp. 3581–
3588, 2011.
[15] M. M. van Timmeren, V. S. Vaidya, R. M. van Ree et al., “High
urinary excretion of kidney injurymolecule-1 is an independent
predictor of graft loss in renal transplant recipients,” Transplan-
tation, vol. 84, no. 12, pp. 1625–1630, 2007.
[16] P. L. Zhang, L. I. Rothblum, W. K. Han, T. M. Blasick, S. Potdar,
and J. V. Bonventre, “Kidney injury molecule-1 expression in
transplant biopsies is a sensitive measure of cell injury,” Kidney
International, vol. 73, no. 5, pp. 608–614, 2008.
[17] X. Zhao, Y. Zhang, L. Li et al., “Glomerular expression of kidney
injury molecule-1 and podocytopenia in diabetic glomerulopa-
thy,”TheAmerican Journal of Nephrology, vol. 34, no. 3, pp. 268–
280, 2011.
[18] G. D’Amico and C. Bazzi, “Pathophysiology of proteinuria,”
Kidney International, vol. 63, no. 3, pp. 809–825, 2003.
[19] C. Bazzi, C. Petrini, V. Rizza, G. Arrigo, and G. D’Amico, “A
modern approach to selectivity of proteinuria tubulointerstitial
damage in nephrotic syndrome,” Kidney International, vol. 58,
no. 4, pp. 1732–1741, 2000.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
